Krishna Institute of Medical Sciences Limited
KIMS · Hospitals · NSE
₹668
Current Market Price
Fair Value (DCF)
₹286
Margin of Safety
-57.1%
Updated 18h ago
YieldIQ Score
40/100
Piotroski F-Score
5/9
Economic Moat
Narrow
Confidence
19%
ROE
15.9%
Debt/Equity
0.00
WACC
9.8%
Market Cap
₹0.27 Lakh Cr
Quality & Valuation
Neutral model outputs — no recommendations.
ROCE
13.2%
Return on capital employed
EV / EBITDA
36.7×
Enterprise multiple
Debt / EBITDA
3.9×
Leverage vs earnings
Interest Coverage
7.3×
EBIT covers interest
Current Ratio
0.83×
Short-term liquidity
Asset Turnover
0.54×
Revenue per ₹ of assets
Revenue CAGR (3Y)
—
3-year revenue growth
Revenue CAGR (5Y)
22.0%
5-year revenue growth
DCF Scenario Analysis
vs CMP ₹667.6
Bear case
₹160.42
MoS -316.2%
Base case
₹286.4
MoS -133.1%
Bull case
₹403.52
MoS -65.4%
Ratio Trends
KIMS · last 5 annual periods
ROE
15.9%
ROCE
16.6%
Operating Margin
—
Debt / Equity
1.06×
PE
113.7×
EV / EBITDA
17.4×
Historical Financials
KIMS · Annual, last 5 years· amounts in ₹Cr unless noted
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 | CAGR |
|---|---|---|---|---|---|---|
| Revenue | ₹1330 Cr | ₹1651 Cr | ₹576 Cr | ₹634 Cr | ₹3004 Cr | +22.6% |
| EBITDA | — | ₹546 Cr | ₹643 Cr | ₹652 Cr | ₹824 Cr | +10.9% |
| EBIT | ₹312 Cr | ₹463 Cr | ₹133 Cr | ₹116 Cr | — | -21.8% |
| PAT | ₹205 Cr | ₹344 Cr | ₹98.7 Cr | ₹71.5 Cr | ₹385 Cr | +17.0% |
| EPS (diluted) | ₹26.20 | ₹41.88 | ₹11.65 | ₹8.18 | — | -25.2% |
| CFO | ₹356 Cr | ₹520 Cr | ₹432 Cr | ₹521 Cr | ₹582 Cr | +13.1% |
| CapEx | — | — | — | — | ₹-1009 Cr | — |
| FCF | — | — | — | — | ₹-427 Cr | — |
| Total Assets | — | ₹1907 Cr | ₹2941 Cr | ₹3852 Cr | ₹5736 Cr | +31.7% |
| Total Debt | — | — | ₹44.6 Cr | ₹129 Cr | ₹2557 Cr | +175.2% |
| Shareholders' Equity | — | — | ₹1670 Cr | ₹1828 Cr | ₹2419 Cr | +9.7% |
CAGR computed across the visible window. Signs reverse if start value is zero or negative.
Peer Comparison
KIMS vs 5 closest peers by market-cap band
| Peer | MoS | Score | Verdict | ROE | PE |
|---|---|---|---|---|---|
| MEDANTA MEDANTA | — | — | Pending | 14.2% | — |
| ASTERDM ASTERDM | — | — | Pending | 147.3% | — |
| NH NH | — | — | Pending | 21.8% | — |
| FORTIS FORTIS | — | — | Pending | 8.4% | — |
| MAXHEALTH MAXHEALTH | — | — | Pending | 11.5% | — |
Click a ticker to view its fair-value analysis.
Dividend History
No dividend events recorded for KIMS in the last 10 years.
Reverse DCF
Market-implied growth
What FCF growth is priced in →
Risk Analysis
Volatility & drawdown
Risk profile of KIMS →
DuPont
ROE decomposition
Why ROE is what it is →
Technicals
RSI, MACD, MAs
Reference indicators →
News & Filings
Recent activity
BSE filings + news for KIMS →
Compare
Head-to-head with peers
Compare KIMS side by side →
Run Full Interactive Analysis
Interactive DCF sliders, sensitivity heatmap, peer comparison, and more.
Analyse KIMSNow →Model estimates using publicly available data. Not investment advice. YieldIQ is not registered with SEBI as an investment adviser or research analyst. Past performance does not guarantee future results.